Please assess the completion status of the following clinical trial:

Trial Title: Family Planning Counseling for Women With Chronic Medical Conditions in an Inpatient Setting

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Currently admitted to the hospital~* Has one or more qualifying chronic medication conditions listed in their chart (hypertension, obesity with BMI\>35, diabetes, current or history of breast cancer, rheumatoid arthritis, sickle cell disease, or lupus)~Exclusion Criteria:~* Currently pregnant~* Using surgical or non-surgical contraception~* Immediately post-partum or admitted to the gynecology service~* Non-English speaking~* Non-verbal or too ill to consent

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: f

Study Arms:
- Bedside Family Planning Counseling (Type: EXPERIMENTAL): Patient is screened for pregnancy intention and then has a bedside family planning counseling session with the investigator taking into account pregnancy intention, medical conditions, medications, and previous contraception used. At the end of the conversation, if patient is desiring contraception, the patient is offered three contraception options (as appropriate for their medical conditions and paid for as part of the study) to be initiated prior to discharge: Etonogestrel implant, medroxyprogesterone 150 mg IM injection, or a year's supply of oral contraception pills.
- Flyer (Type: EXPERIMENTAL): Patient is given a flyer that recommends they discuss pregnancy intention and contraception with their OB/GYN or primary care physician.
- Routine care (Type: NO_INTERVENTION): Patients receive a deception consent so as not to influence them by the consent process. Consent states that the purpose of the project is to study patterns of birth control usage of women admitted to the hospital. Patient is not given any further intervention.

Based on this trial design, predict the completion outcome and termination type (if applicable).